Immunochromatography Analysis Device for Detecting Gliadin, Immunochromatography Analysis Kit and Immunochromatography Analysis Method
AssigneeTanaka Kikinzoku Kogyo K.K.
InventorsKeita SUZUKI, Hiroko MOCHIZUKI, Hisahiko IWAMOTO
Life of this patent
Estimating the term…
Abstract
An object of the present invention is to provide an immunochromatography analysis device for detecting gliadin in which a cross-reaction with an antigen in a food other than gliadin is inhibited and which has improved specificity and the invention relates to an immunochromatography analysis device for detecting gliadin including a sample addition part, a labeling substance retaining part, a chromatography medium part having a detection part and an absorption part, wherein the labeling substance retaining part and the detection part contains an antibody recognizing α-gliadin.
Claims6
An immunochromatography analysis device for detecting gliadin, including a sample addition part, a labeling substance retaining part, a chromatography medium part having a detection part and an absorption part,
- wherein the labeling substance retaining part and the detection part contain an antibody recognizing α-gliadin, and the antibody contained in the labeling substance retaining part and the antibody contained in the detection part are a same antibody.
An immunochromatography analysis method for detecting gliadin in an analyte with using an immunochromatography analysis device including a sample addition part, a labeling substance retaining part, a chromatography medium part having a detection part and an absorption part, wherein the method includes the following steps (1) to (4):
- (1) a step of adding an analyte-containing solution obtained by diluting the analyte with an analyte dilution solution to the sample addition part,
- (2) a step of allowing an antibody recognizing α-gliadin held in the labeling substance retaining part to recognize gliadin,
- (3) a step of developing the analyte and the antibody as a mobile phase on the chromatography medium part, and
- (4) a step of detecting gliadin in the developed mobile phase with an antibody recognizing α-gliadin which is contained in the detection part and which is the same as the antibody held in the labeling substance retaining part.
(canceled)
Dependencies are inferred from the claim text.